North America Patient Registry Software Market to Grow at a CAGR of 13.6% to reach US$ 943.2 million from 2021 to 2027

North America Patient Registry Software Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Software (Standalone, and Integrated); Database (Public, and Commercial); Type of Registry (Product Registries, Disease Registries, and Health Service Registries); Mode of Delivery (On Premise, and Cloud Based); and Pricing Model (Subscription, and Ownership)

  • Report Code : TIPRE00010246
  • Category : Healthcare IT
  • Status : Published
  • No. of Pages : 129
Buy Now

The North America patient registry software market is expected to grow from US$ 385.9 million in 2020 to US$ 943.2 million by 2027; it is estimated to grow at a CAGR of 13.6% from 2020 to 2027.



The ongoing revolution of digital infrastructure in healthcare across the region is spurred by regulations enforced and investments provided by the government authorities. In addition, rising demand for data collection for analysis and increasing pressure on healthcare providers to reduce the cost of treatments and procedures are leading to the progress of healthcare digitalization in countries worldwide. Moreover, in 2017, the former president of the US (Barack Obama) introduced the Health Information Technology for Economic and Clinical Health (HITECH) Act of 2009. This legislation offered financial incentives to healthcare providers to incorporate IT solutions in various processes, whereas enforced financial penalties on those who didn’t. This initiative led to massive increase in the adoption of electronic health records (EHRs) and patient registries for the evaluation of specified outcomes for patients who are suffering from a particular disease or condition. Therefore, the surging incorporation of digital tools in the healthcare structure drives the growth of the patient registry software market.

The effectiveness of patient registry software to gather and analyze patient data is expected to have constructive impact on the adoption of patient registry software in the region. Moreover, majority of the market players, research centers, and academic institutions are focusing on the adoption of patient registries with an aim to streamline the patient data collection and analysis. In February 2021, the Leukemia & Lymphoma Society (LLS) announced strategic partnership with Ciitizen, a significant player in digital health solution in order to study on the relation between coronavirus and vaccination amongst blood cancer patients. The institution launched LLS National Patient Registry in order to gather data of blood cancer patients for the study. Further, in April 2020, the American Heart Association announced development of a novel patient registry to collect data, which will help the researchers to understand co-relation between coronavirus, cardiovascular diseases, and related treatment protocols. Moreover, in July 2020, Oracle and the National Institutes of Health (NIH) established a patient data registry to gather COVID-19 patients’ data. The partnership has termed this platform as COVID-19 Prevention Network (CoVPN). In addition, in April 2020, IQVIA Inc. announced the launch of a broad and open patient registry platform for advanced understanding and research of covid-19. These developments are likely to have constructive impact on the North America patient registry software market during and post-pandemic period.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the patient registry software market. The North America patient registry software market is expected to grow at a good CAGR during the forecast period.


  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

North America Patient Registry Software Market Segmentation          

By Software

  • Standalone
  • Integrated

By Database

  • Public
  • Commercial

By Type of Registry

  • Product Registry
  • Disease Registry
    • Cardiovascular Disease Registry
    • Others
  • Health Service Registry

By Mode of Delivery

  • On-Premises
  • Cloud-Based

By Pricing Model

  • Ownership
  • Subscription

By Country

  • North America

    • US
    • Canada
    • Mexico

Companies Mentioned

  • IQVIA Inc.
  • FIGmd Inc.
  • Medstreaming
  • Open Text Corporation
  • Evado Clinical
  • LUMEDX
  • CEDARON
  • IBM Corporation
  • Mckesson Corporation
  • Dacima Software Inc
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Software, Database, Type of Registry, Mode of Delivery, and Pricing Model

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

US, Canada

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Patient Registry Software Market – By Software

1.3.2 Patient Registry Software Market – By Database

1.3.3 Patient Registry Software Market – By Type of Registry

1.3.4 Patient Registry Software Market – By Mode of Delivery

1.3.5 Patient Registry Software Market – By Pricing Model

1.3.6 North America Patient Registry Software Market – By Country

2. North America Patient Registry Software Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Patient Registry Software Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Patient Registry Software Market- North America PEST Analysis

4.3 Expert Opinion

5. North America Patient Registry Software Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Development of Digital Infrastructure in Healthcare

5.1.2 Increasing Use of Patient Registries

5.2 Market Restraints

5.2.1 Threats of Data Breach

5.3 Market Opportunities

5.3.1 Emergence of Cloud-Based Patient Registries

5.4 Future Trends

5.4.1 Development of Registries for Medical Devices

5.5 Impact Analysis

6. Patient Registry Software Market – North America Analysis

6.1 North America Patient Registry Software Market Revenue Forecasts and Analysis

7. North America Patient Registry Software Market Analysis and Forecasts To 2027 – By Software

7.1 Overview

7.2 Patient Registry Software Market Revenue Share, by Software (2019 and 2027)

7.3 Standalone

7.3.1 Overview

7.3.2 Standalone: Patient Registry Software Market – Revenue and Forecast to 2027 (US$ Million)

7.4 Integrated

7.4.1 Overview

7.4.2 Integrated: Patient Registry Software Market – Revenue and Forecast to 2027 (US$ Million)

8. North America Patient Registry Software Market Analysis and Forecasts To 2027 – By Database

8.1 Overview

8.2 Patient Registry Software Market, by Database, 2019 and 2027 (%)

8.3 Public

8.3.1 Overview

8.3.2 Public: Patient Registry Software Market – Revenue and Forecast to 2027 (US$ Million)

8.4 Commercial

8.4.1 Overview

8.4.2 Commercial: Patient Registry Software Market – Revenue and Forecast to 2027 (US$ Million)

9. North America Patient Registry Software Market Analysis and Forecasts To 2027 – By Type of Registry

9.1 Overview

9.2 Patient Registry Software Market, by Type of Registry, 2019 and 2027 (%)

9.3 Product Registry

9.3.1 Overview

9.3.2 Product Registry: Patient Registry Software Market – Revenue and Forecast to 2027 (US$ Million)

9.4 Disease Registry

9.4.1 Overview

9.4.2 Disease Registry: Patient Registry Software Market – Revenue and Forecast to 2027 (US$ Million)

9.4.3 Cardiovascular Disease Registry

9.4.3.1 Overview

9.4.3.2 Cardiovascular Disease Registry: Patient Registry Software Market – Revenue and Forecast to 2027 (US$ Million)

9.4.4 Others

9.4.4.1 Overview

9.4.4.2 Others: Patient Registry Software Market – Revenue and Forecast to 2027 (US$ Million)

9.5 Health Service Registry

9.5.1 Overview

9.5.2 Health Service Registry: Patient Registry Software Market – Revenue and Forecast to 2027 (US$ Million)

10. North America Patient Registry Software Market Analysis and Forecasts To 2027 – By Mode of Delivery

10.1 Overview

10.2 Patient Registry Software Market, by Mode of Delivery, 2019 and 2027 (%)

10.3 On Premise

10.3.1 Overview

10.3.2 On Premise: Patient Registry Software Market – Revenue and Forecast to 2027 (US$ Million)

10.4 Cloud-Based

10.4.1 Overview

10.4.2 Cloud-Based: Patient Registry Software Market – Revenue and Forecast to 2027 (US$ Million)

11. North America Patient Registry Software Market Analysis and Forecasts to 2027– By Pricing Model

11.1 Overview

11.2 Patient Registry Software Market, by Pricing Model, 2019 and 2027 (%)

11.3 Subscription

11.3.1 Overview

11.3.2 Subscription: Patient Registry Software Market – Revenue and Forecast to 2027 (US$ Million)

11.4 Ownership

11.4.1 Overview

11.4.2 Ownership: Patient Registry Software Market – Revenue and Forecast to 2027 (US$ Million)

12. Patient Registry Software Market Revenue and Forecasts to 2027 – Geographical Analysis

12.1 North America: Patient Registry Software Market

12.1.1 Overview

12.1.2 North America: Patient Registry Software Market, by Country, 2019 & 2027 (%)

12.1.3 US: Patient Registry Software Market – Revenue and Forecast to 2027 (USD Million)

12.1.3.1 US: Patient Registry Software Market – Revenue and Forecast to 2027 (USD Million)

12.1.3.2 US: Patient Registry Software Market, by Software, 2018–2027 (USD Million)

12.1.3.3 US: Patient Registry Software Market, by Database, 2018–2027 (USD Million)

12.1.3.4 US: Patient Registry Software Market, by Type of Registry, 2018–2027 (USD Million)

12.1.3.4.1 US: Disease Registry Market, by Type, 2018–2027 (USD Million)

12.1.3.5 US: Patient Registry Software Market, by Mode of Delivery, 2018–2027 (USD Million)

12.1.3.6 US: Patient Registry Software Market, by Pricing Model, 2018–2027 (USD Million)

12.1.4 Canada: Patient Registry Software Market – Revenue and Forecast to 2027 (USD Million)

12.1.4.1 Canada: Patient Registry Software Market – Revenue and Forecast to 2027 (USD Million)

12.1.4.2 Canada: Patient Registry Software Market, by Software, 2018–2027 (USD Million)

12.1.4.3 Canada: Patient Registry Software Market, by Database, 2018–2027 (USD Million)

12.1.4.4 Canada: Patient Registry Software Market, by Type of Registry, 2018–2027 (USD Million)

12.1.4.4.1 Canada: Disease Registry Market, by Type, 2018–2027 (USD Million)

12.1.4.5 Canada: Patient Registry Software Market, by Mode of Delivery, 2018–2027 (USD Million)

12.1.4.6 Canada: Patient Registry Software Market, by Pricing Model, 2018–2027 (USD Million)

12.1.5 Mexico: Patient Registry Software Market – Revenue and Forecast to 2027 (USD Million)

12.1.5.1 Mexico: Patient Registry Software Market – Revenue and Forecast to 2027 (USD Million)

12.1.5.2 Mexico: Patient Registry Software Market, by Software, 2018–2027 (USD Million)

12.1.5.3 Mexico: Patient Registry Software Market, by Database, 2018–2027 (USD Million)

12.1.5.4 Mexico: Patient Registry Software Market, by Type of Registry, 2018–2027 (USD Million)

12.1.5.4.1 Mexico: Disease Registry Market, by Type, 2018–2027 (USD Million)

12.1.5.5 Mexico: Patient Registry Software Market, by Mode of Delivery, 2018–2027 (USD Million)

12.1.5.6 Mexico: Patient Registry Software Market, by Pricing Model, 2018–2027 (USD Million)

13. Impact Of COVID-19 Pandemic on North America Patient Registry Software Market

13.1 North America: Impact Assessment of COVID-19 Pandemic

14. Industry Landscape

14.1 Overview

14.2 Growth Strategies Done by the Companies in the Market, (%)

14.3 Organic Developments

14.3.1 Overview

14.4 Inorganic Developments

14.4.1 Overview

15. COMPANY PROFILES

15.1 IQVIA Inc.

15.1.1 Key Facts

15.1.2 Business Description

15.1.3 Products and Services

15.1.4 Financial Overview

15.1.5 SWOT Analysis

15.1.6 Key Developments

15.2 FIGmd Inc.

15.2.1 Key Facts

15.2.2 Business Description

15.2.3 Products and Services

15.2.4 Financial Overview

15.2.5 SWOT Analysis

15.2.6 Key Developments

15.3 Medstreaming

15.3.1 Key Facts

15.3.2 Business Description

15.3.3 Products and Services

15.3.4 Financial Overview

15.3.5 SWOT Analysis

15.3.6 Key Developments

15.4 Open Text Corporation

15.4.1 Key Facts

15.4.2 Business Description

15.4.3 Products and Services

15.4.4 Financial Overview

15.4.5 SWOT Analysis

15.4.6 Key Developments

15.5 Evado Clinical

15.5.1 Key Facts

15.5.2 Business Description

15.5.3 Products and Services

15.5.4 Financial Overview

15.5.5 SWOT Analysis

15.5.6 Key Developments

15.6 LUMEDX

15.6.1 Key Facts

15.6.2 Business Description

15.6.3 Products and Services

15.6.4 Financial Overview

15.6.5 SWOT Analysis

15.6.6 Key Developments

15.7 CEDARON

15.7.1 Key Facts

15.7.2 Business Description

15.7.3 Products and Services

15.7.4 Financial Overview

15.7.5 SWOT Analysis

15.7.6 Key Developments

15.8 IBM Corporation

15.8.1 Key Facts

15.8.2 Business Description

15.8.3 Products and Services

15.8.4 Financial Overview

15.8.5 SWOT Analysis

15.8.6 Key Developments

15.9 McKESSON CORPORATION

15.9.1 Key Facts

15.9.2 Business Description

15.9.3 Products and Services

15.9.4 Financial Overview

15.9.5 SWOT Analysis

15.9.6 Key Developments

15.10 Dacima Software Inc.

15.10.1 Key Facts

15.10.2 Business Description

15.10.3 Products and Services

15.10.4 Financial Overview

15.10.5 SWOT Analysis

15.10.6 Key Developments

16. Appendix

16.1 About the Insight Partners

16.2 Glossary of Terms

LIST OF TABLES

Table 1. US Patient Registry Software Market, by Software – Revenue and Forecast to 2027 (USD Million)

Table 2. US Patient Registry Software Market, by Database – Revenue and Forecast to 2027 (USD Million)

Table 3. US Patient Registry Software Market, by Type of Registry – Revenue and Forecast to 2027 (USD Million)

Table 4. US Disease Registry Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 5. US Patient Registry Software Market, by Mode of Delivery – Revenue and Forecast to 2027 (USD Million)

Table 6. US Patient Registry Software Market, by Pricing Model – Revenue and Forecast to 2027 (USD Million)

Table 7. Canada Patient Registry Software Market, by Software – Revenue and Forecast to 2027 (USD Million)

Table 8. Canada Patient Registry Software Market, by Database – Revenue and Forecast to 2027 (USD Million)

Table 9. Canada Patient Registry Software Market, by Type of Registry – Revenue and Forecast to 2027 (USD Million)

Table 10. Canada Disease Registry Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 11. Canada Patient Registry Software Market, by Mode of Delivery – Revenue and Forecast to 2027 (USD Million)

Table 12. Canada Patient Registry Software Market, by Pricing Model – Revenue and Forecast to 2027 (USD Million)

Table 13. Mexico Patient Registry Software Market, by Software – Revenue and Forecast to 2027 (USD Million)

Table 14. Mexico Patient Registry Software Market, by Database – Revenue and Forecast to 2027 (USD Million)

Table 15. Mexico Patient Registry Software Market, by Type of Registry – Revenue and Forecast to 2027 (USD Million)

Table 16. Mexico Disease Registry Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 17. Mexico Patient Registry Software Market, by Mode of Delivery – Revenue and Forecast to 2027 (USD Million)

Table 18. Mexico Patient Registry Software Market, by Pricing Model – Revenue and Forecast to 2027 (USD Million)

Table 19. Organic Developments Done by Companies

Table 20. Inorganic Developments Done by Companies

Table 21. Glossary of Terms, Patient Registry Software Market

LIST OF FIGURES

Figure 1. Patient Registry Software Market Segmentation

Figure 2. North America Patient Registry Software Market Overview

Figure 3. Integrated Segment Held Largest Share of Software in Patient Registry Software Market

Figure 4. Subscription Segment Held Largest Share of Pricing Model in Patient Registry Software Market

Figure 5. US is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Patient Registry Software Market - North America PEST Analysis

Figure 7. Patient Registry Software Market Impact Analysis of Driver and Restraints

Figure 8. North America Patient Registry Software Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9. Patient Registry Software Market Revenue Share, by Software (2019 and 2027)

Figure 10. Standalone: Patient Registry Software Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11. Integrated: Patient Registry Software Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12. Patient Registry Software Market, by Database, 2019 and 2027 (%)

Figure 13. Public: Patient Registry Software Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14. Commercial: Patient Registry Software Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15. Patient Registry Software Market, by Type of Registry, 2019 and 2027 (%)

Figure 16. Product Registry: Patient Registry Software Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17. Disease Registry: Patient Registry Software Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18. Cardiovascular Disease Registry: Patient Registry Software Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19. Others: Patient Registry Software Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20. Health Service Registry: Patient Registry Software Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21. Patient Registry Software Market, by Mode of Delivery, 2019 and 2027 (%)

Figure 22. On Premise: Patient Registry Software Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23. Cloud-Based: Patient Registry Software Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24. Patient Registry Software Market, by Pricing Model, 2019 and 2027 (%)

Figure 25. Subscription: Patient Registry Software Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26. Ownership: Patient Registry Software Market – Revenue and Forecast to 2027 (US$ Million)

Figure 27. North America: Patient Registry Software Market, by Key Country – Revenue (2019) (USD Million)

Figure 28. North America: Patient Registry Software Market, by Country, 2019 & 2027 (%)

Figure 29. US: Patient Registry Software Market – Revenue and Forecast to 2027 (USD Million)

Figure 30. Canada: Patient Registry Software Market – Revenue and Forecast to 2027 (USD Million)

Figure 31. Mexico: Patient Registry Software Market – Revenue and Forecast to 2027 (USD Million)

Figure 32. Impact of COVID-19 Pandemic in North American Country Markets

Figure 33. Growth Strategies Done by the Companies in the Market, (%)

The List of Companies - North America Patient Registry Software Market

 

  1. IQVIA Inc.
  2. FIGmd Inc.
  3. Medstreaming
  4. Open Text Corporation
  5. Evado Clinical
  6. LUMEDX
  7. CEDARON
  8. IBM Corporation
  9. Mckesson Corporation
  10. Dacima Software Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to North America Patient Registry Software Market